Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Teva
Queensland Health
Baxter
Medtronic
AstraZeneca
Healthtrust
Merck
Accenture
Boehringer Ingelheim

Generated: October 17, 2017

DrugPatentWatch Database Preview

CHOLYBAR Drug Profile

« Back to Dashboard

Which patents cover Cholybar, and what generic Cholybar alternatives are available?

Cholybar is a drug marketed by Parke Davis and is included in two NDAs.

The generic ingredient in CHOLYBAR is cholestyramine. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for Tradename: CHOLYBAR

US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHOLYBAR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071621-001May 26, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071739-001May 26, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CHOLYBAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071621-001May 26, 1988► Subscribe► Subscribe
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071739-001May 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Julphar
Healthtrust
Accenture
Harvard Business School
Fuji
Novartis
Deloitte
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot